In Situ Vaccination and Immune Checkpoint Blockade for Lymphoma Tumors

In Situ Vaccination and Immune Checkpoint Blockade for Lymphoma Tumors

User Photo
ASHReport

4 years
572 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Joshua Brody, MD, PhD, of Mount Sinai Hospital, discusses his abstract on Combining In Situ Vaccination with Immune Checkpoint Blockade Induces Long-Term Regression of Lymphoma Tumors at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>